Oppenheimer analyst Jay Olson lowered the price target on Tvardi Therapeutics Inc (NASDAQ: TVRD) to $10.00 (from $65.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE